| Authors: |
Veljovich DS; Swedish Cancer Institute, Seattle, WA., Rothe M; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Ali-Ahmad HM; Michigan Cancer Research Consortium, Lansing, MI., Naumann RW; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Siedel J; University of Michigan, Ann Arbor, MI., Chan JK; Sutter Cancer Research Consortium, San Francisco, CA., Gregory A; Advocate Aurora Healthcare, Milwaukee, WI., Pisick E; City of Hope Chicago, Zion, IL., Adesunloye B; City of Hope Atlanta, Atlanta, GA., Arend RC; Division of Gynecologic Oncology, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL., Bell M; Sanford Health, Sioux Falls, SD., Frimer M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Northwell Health Cancer Institute, New Hyde Park, NY., Tawfik B; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM., Thota R; Intermountain Healthcare, Murray, UT., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Hinshaw DC; American Society of Clinical Oncology, Alexandria, VA., Gregory A; American Society of Clinical Oncology, Alexandria, VA., Grantham GN; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA. |
